Patient Case Outcome Underscores Potential of Cagent Vascular’s Serration Remodeling Therapy

According to a recent LinkedIn post from Cagent Vascular Inc, a highlighted patient case involving Dr. Sagar Gandhi describes a high-risk limb salvage scenario treated with the company’s Serration Remodeling Therapy, or SRT. The case reportedly progressed from stalled wound healing to complete wound closure in 90 days, with the vessel described as effectively remodeled and supporting durable outcomes.

The post suggests that SRT may have clinical relevance in peripheral artery disease and chronic limb-threatening ischemia, areas where limb salvage is a key treatment goal. For investors, such positive case-based outcomes, if replicated at scale and supported by robust clinical data, could enhance Cagent Vascular’s value proposition versus competing endovascular technologies and potentially support adoption, reimbursement discussions, and longer-term revenue prospects in the PAD/CLTI market.